ATE387204T1 - Zusammensetzung mit induzierendem kathartischen effekt - Google Patents

Zusammensetzung mit induzierendem kathartischen effekt

Info

Publication number
ATE387204T1
ATE387204T1 AT02771715T AT02771715T ATE387204T1 AT E387204 T1 ATE387204 T1 AT E387204T1 AT 02771715 T AT02771715 T AT 02771715T AT 02771715 T AT02771715 T AT 02771715T AT E387204 T1 ATE387204 T1 AT E387204T1
Authority
AT
Austria
Prior art keywords
inducing
composition
cathartic effect
cathartic
effect
Prior art date
Application number
AT02771715T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of ATE387204T1 publication Critical patent/ATE387204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02771715T 2001-05-18 2002-05-17 Zusammensetzung mit induzierendem kathartischen effekt ATE387204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29163501P 2001-05-18 2001-05-18

Publications (1)

Publication Number Publication Date
ATE387204T1 true ATE387204T1 (de) 2008-03-15

Family

ID=23121127

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02771715T ATE387204T1 (de) 2001-05-18 2002-05-17 Zusammensetzung mit induzierendem kathartischen effekt

Country Status (18)

Country Link
US (2) US6956056B2 (de)
EP (1) EP1389116B1 (de)
JP (1) JP4597481B2 (de)
KR (1) KR100867295B1 (de)
CN (1) CN1273140C (de)
AR (3) AR035242A1 (de)
AT (1) ATE387204T1 (de)
AU (1) AU2002307725B2 (de)
BR (1) BR0209863A (de)
CA (1) CA2445651C (de)
DE (1) DE60225266T2 (de)
DK (1) DK1389116T3 (de)
ES (1) ES2301681T3 (de)
MX (1) MXPA03010510A (de)
NZ (1) NZ529406A (de)
PT (1) PT1389116E (de)
TW (2) TWI320711B (de)
WO (1) WO2002094274A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
WO2004037268A1 (en) * 2002-10-23 2004-05-06 Sucampo Ag Prostaglandin compounds for the treatment of obesity
JP4889219B2 (ja) 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
US7049319B2 (en) 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
TWI387454B (zh) 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US20070071793A1 (en) * 2005-09-23 2007-03-29 Leon Clark Cure for prostate enlargement frequency of urination and cancer
JP4851467B2 (ja) * 2006-02-07 2012-01-11 株式会社アールテック・ウエノ プロスタグランジン誘導体の製造法
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
JP6499591B2 (ja) * 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
JP6957610B2 (ja) 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ
US10457623B1 (en) * 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1396207A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandin intermediates and the preparation thereof
US3969376A (en) * 1973-07-20 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
ZA744580B (en) * 1973-07-20 1975-07-30 Upjohn Co Prostaglandin analogs
US3969379A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US3969381A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
GB8305697D0 (en) * 1983-03-02 1983-04-07 Erba Farmitalia Pharmaceutical compositions
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
EP0310305B1 (de) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Kathartica
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
EP0455448B1 (de) 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
ES2182088T3 (es) * 1996-06-10 2003-03-01 Sucampo Ag Antagonista de la endotelina.
CA2458471C (en) * 2001-08-31 2012-07-31 Sucampo Ag Prostaglandin analogs as chloride channel opener

Also Published As

Publication number Publication date
WO2002094274A1 (en) 2002-11-28
CA2445651A1 (en) 2002-11-28
US7459583B2 (en) 2008-12-02
US20050261375A1 (en) 2005-11-24
TWI324589B (en) 2010-05-11
US6956056B2 (en) 2005-10-18
DE60225266D1 (de) 2008-04-10
AR035242A1 (es) 2004-05-05
JP2004529960A (ja) 2004-09-30
DK1389116T3 (da) 2008-06-23
PT1389116E (pt) 2008-04-11
TWI320711B (en) 2010-02-21
BR0209863A (pt) 2004-06-08
TW200944210A (en) 2009-11-01
US20030022933A1 (en) 2003-01-30
AU2002307725B2 (en) 2008-07-10
EP1389116B1 (de) 2008-02-27
AR098744A2 (es) 2016-06-08
EP1389116A1 (de) 2004-02-18
NZ529406A (en) 2005-09-30
AR110149A2 (es) 2019-02-27
CA2445651C (en) 2011-08-09
KR100867295B1 (ko) 2008-11-06
CN1273140C (zh) 2006-09-06
KR20040020055A (ko) 2004-03-06
DE60225266T2 (de) 2009-03-19
ES2301681T3 (es) 2008-07-01
JP4597481B2 (ja) 2010-12-15
MXPA03010510A (es) 2004-03-02
CN1509176A (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
DE60209785D1 (de) Gipszusammensetzung mit verbesserter deformationsstabilität
IS6915A (is) Lyfjablanda
DE60200746D1 (de) Kautschukzusammensetzung
IS2932B (is) Fúlvestrant samsetning
DE60140246D1 (de) Wärmende Zusammensetzung
EP1391476A4 (de) Photoreaktive zusammensetzung
DK1390066T3 (da) Vaccinesammensætning
DE60209302D1 (de) Elektronisch leitfähige Polythiophenteilchen enthaltende Zusammensetzung
DE50201677D1 (de) Farbmittelkomposition
BR0210619A (pt) composição
DE10290365T1 (de) Gummizusammensetzung
IS7081A (is) Lyfjablanda
DE60212442D1 (de) Kautschukzusammensetzung
DK1186631T3 (da) Gummisammensætning
DE60102050D1 (de) Glaszusammensetzung
DE60129749D1 (de) Kautschukzusammensetzung
ATE387204T1 (de) Zusammensetzung mit induzierendem kathartischen effekt
DE60116858D1 (de) Zusammensetzung
DE60143148D1 (de) En mit honigwaben
DE60107894D1 (de) Kautschukzusammensetzung
DK1451433T3 (da) Glassammensætning
DE60234481D1 (de) Verschachtelungsverfahren
DE60200162D1 (de) Härtungszusammensetzung
DE60236587D1 (de) Latexzusammensetzung
ITTO20020747A0 (it) Composizione

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1389116

Country of ref document: EP